Evidence map›Paper›PMID 37751398›Full record

ArticleBioconjugate chemistry2023

Site-Specific

Thomas T C Yue, Ying Ge, Francesco A Aprile, Michelle T Ma, Truc T Pham, Nicholas J Long

Open access · hybridAbstract read
In one paragraph

Article in Bioconjugate chemistry, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Exploiting thioether reactivity to label mycobacterial glycans.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  5. Review
  6. Review
  7. Site-specific bioconjugation and nuclear imaging.Current opinion in chemical biology · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Thomas T C YueDepartment of Chemistry, Molecular Sciences Research Hub, Imperial College London, White City Campus, Wood Lane, London W120BZ, U.K.
Ying GeDepartment of Chemistry, Molecular Sciences Research Hub, Imperial College London, White City Campus, Wood Lane, London W120BZ, U.K.ORCID 0000-0002-7423-1296
Francesco A AprileDepartment of Chemistry and Institute of Chemical Biology, Molecular Sciences Research Hub, Imperial College London, White City Campus, Wood Lane, London W120BZ, U.K.ORCID 0000-0002-5040-4420
Michelle T MaSchool of Biomedical Engineering and Imaging Sciences, King's College London, Fourth Floor Lambeth Wing, St. Thomas' Hospital, London SE17EH, U.K.ORCID 0000-0002-3349-7346
Truc T PhamSchool of Biomedical Engineering and Imaging Sciences, King's College London, Fourth Floor Lambeth Wing, St. Thomas' Hospital, London SE17EH, U.K.ORCID 0000-0001-5850-4592
Nicholas J LongDepartment of Chemistry and Institute of Chemical Biology, Molecular Sciences Research Hub, Imperial College London, White City Campus, Wood Lane, London W120BZ, U.K.ORCID 0000-0002-8298-938X
London Biofoundry · GBSt Thomas' Hospital · GB

Funding

Medical Research Council MR/S033947/1Wellcome Trust
6 · The paper itself

Abstract

Bioconjugates of antibodies and their derivatives radiolabeled with β

Indexed as

ImmunoconjugatesNeoplasmsAnimalsCell Line, TumorChelating AgentsDeferoxamineGallium RadioisotopesMethionineMicePositron-Emission TomographyRacemethionineTissue DistributionTrastuzumabZirconiumChelating AgentsDeferoxamineGallium RadioisotopesImmunoconjugatesMethionineRacemethionineTrastuzumabZirconium

Identifiers

PMID37751398
PMCPMC10587866
OpenAlexW4387043492

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.